Xiaodi Yan

550 total citations
30 papers, 430 citations indexed

About

Xiaodi Yan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaodi Yan has authored 30 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Xiaodi Yan's work include Cancer, Hypoxia, and Metabolism (7 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Xiaodi Yan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). Xiaodi Yan collaborates with scholars based in China, Hong Kong and India. Xiaodi Yan's co-authors include Ninghua Yao, Juan Wei, Dengfu Yao, Liwei Qiu, Min Yao, Liang Xiao, Yuanli Chen, Xin Lv, Ming Zhong and Dandan Yu and has published in prestigious journals such as Nature Cell Biology, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Xiaodi Yan

29 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaodi Yan China	12	290	136	72	57	57	30	430
Yunwei Guo China	11	231 0.8×	170 1.3×	114 1.6×	45 0.8×	64 1.1×	28	462
Karina Cunha e Rocha United States	10	223 0.8×	130 1.0×	158 2.2×	49 0.9×	62 1.1×	16	472
Zongqi Zhang China	10	261 0.9×	130 1.0×	75 1.0×	40 0.7×	44 0.8×	22	449
Junliang Pu China	11	243 0.8×	124 0.9×	91 1.3×	37 0.6×	68 1.2×	22	447
Baoyong Zhou China	12	238 0.8×	100 0.7×	92 1.3×	39 0.7×	39 0.7×	40	481
Yiping Dong China	13	239 0.8×	131 1.0×	54 0.8×	59 1.0×	21 0.4×	30	403
Weixue Tang China	13	278 1.0×	160 1.2×	64 0.9×	28 0.5×	18 0.3×	38	507
Limei Wu China	14	341 1.2×	153 1.1×	104 1.4×	46 0.8×	39 0.7×	39	603
Louise Tzung-Harn Hsieh Germany	10	235 0.8×	83 0.6×	91 1.3×	48 0.8×	19 0.3×	14	523

Countries citing papers authored by Xiaodi Yan

Since Specialization

Citations

This map shows the geographic impact of Xiaodi Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodi Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodi Yan more than expected).

Fields of papers citing papers by Xiaodi Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodi Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodi Yan. The network helps show where Xiaodi Yan may publish in the future.

Co-authorship network of co-authors of Xiaodi Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodi Yan. A scholar is included among the top collaborators of Xiaodi Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodi Yan. Xiaodi Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yan, Xiaodi, et al.. (2025). MiR-371b-5p reduces osteosarcoma cell migration and proliferation to induce apoptosis by targeting FUT4. Journal of Cancer. 16(7). 2388–2400.

Yang, Xiaolong, Nannan He, H. J. Yang, et al.. (2025). Spatial transcriptomic characterization of a Carnegie stage 7 human embryo. Nature Cell Biology. 27(2). 360–369. 14 indexed citations

Liang, Pei, et al.. (2024). Serum trough concentration threshold and risk factors of cefoperazone-induced coagulopathy in critically ill patients: A retrospective case-control study. European Journal of Clinical Pharmacology. 80(5). 737–746. 3 indexed citations

Yang, Yang�, Xiaodi Yan, Jiajia Liu, et al.. (2024). Silencing FUT4 Inhibits the Progression of Osteosarcoma through Activation ofFOXO1. Current Pharmaceutical Design. 30(6). 440–447. 3 indexed citations

Liu, Ruiqi, Yanrong Chen, Qiang Xue, et al.. (2024). The prognostic value and potential immunotherapeutic efficacy of ACVR1 in treating gastric cancer. Journal of Gastrointestinal Oncology. 15(1). 63–85. 1 indexed citations

Yan, Xiaodi, et al.. (2023). MSTL-Kace: Prediction of Prokaryotic Lysine Acetylation Sites Based on Multistage Transfer Learning Strategy. ACS Omega. 8(44). 41930–41942. 2 indexed citations

An, Ni, Xiaodi Yan, Hainan Zhao, et al.. (2022). Inhibition of Rac1 attenuates radiation-induced lung injury while suppresses lung tumor in mice. Cell Death Discovery. 8(1). 26–26. 7 indexed citations

Yao, Ninghua, Xiaodi Yan, Jing Qian, et al.. (2022). Systematic analysis of ferroptosis-related long non-coding RNA predicting prognosis in patients with lung squamous cell carcinoma. Translational Lung Cancer Research. 11(4). 632–646. 8 indexed citations

Yan, Xiaodi, et al.. (2022). High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma. Journal of Thoracic Disease. 14(12). 4785–4802. 10 indexed citations

10.

Dai, Xiaoyan, Liang Ma, Xiaodi Yan, et al.. (2021). A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma. Annals of Translational Medicine. 9(6). 500–500. 21 indexed citations

11.

Xue, Qiang, Yang� Yang, Linlin Yang, et al.. (2021). miR-371b-5p-Engineered Exosomes Enhances Tumor Inhibitory Effect. Frontiers in Cell and Developmental Biology. 9. 750171–750171. 23 indexed citations

12.

Shi, Yu, Yan Wang, Jing Qian, et al.. (2020). MGMT expression affects the gemcitabine resistance of pancreatic cancer cells. Life Sciences. 259. 118148–118148. 22 indexed citations

13.

Liu, Tingting, Yajie Yang, Xiaodi Yan, et al.. (2019). A bidirectional effect of Rac1 inhibition—Protects radiation-induced intestinal injury while inhibits tumor. Life Sciences. 240. 117105–117105. 6 indexed citations

14.

Yan, Xiaodi, Wenqian Li, Li–Ye Yang, et al.. (2018). MiR-135a Protects Vascular Endothelial Cells Against Ventilator-Induced Lung Injury by Inhibiting PHLPP2 to Activate PI3K/Akt Pathway. Cellular Physiology and Biochemistry. 48(3). 1245–1258. 28 indexed citations

15.

Cai, Linlin, Yonghua Li, Qingqing Zhang, et al.. (2017). Salidroside protects rat liver against ischemia/reperfusion injury by regulating the GSK-3β/Nrf2-dependent antioxidant response and mitochondrial permeability transition. European Journal of Pharmacology. 806. 32–42. 47 indexed citations

16.

Yao, Min, Li Wang, Junling Yang, et al.. (2016). IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo. Tumor Biology. 37(11). 14677–14686. 7 indexed citations

17.

Yao, Min, Dengfu Yao, Yinzhu Bian, et al.. (2013). Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international. 12(2). 171–179. 40 indexed citations

18.

Yan, Xiaodi. (2013). Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation. World Journal of Gastroenterology. 19(36). 6084–6084. 15 indexed citations

19.

Yao, Ninghua, Dengfu Yao, Li Wang, et al.. (2012). Inhibition of autocrine IGF-II on effect of human HepG2 cell proliferation and angiogenesis factor expression. Tumor Biology. 33(5). 1767–1776. 23 indexed citations

20.

Yu, Dandan, Zhizhen Dong, Min Yao, et al.. (2012). Targeted glypican-3 gene transcription inhibited the proliferation of human hepatoma cells by specific short hairpin RNA. Tumor Biology. 34(2). 661–668. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact